JCI Insight is an Gold Open Access journal that has a 2021 Impact Factor of 9.484. The Journal publishes well-executed, high-quality studies that provide meaningful contributions to the understanding of the biology and/or treatment of disease, with an emphasis on clinically relevant basic and translational research.
An enzyme-based treatment developed by Yale researchers mitigated autoimmunity and reduced death rates in both genetic and non-genetic mouse lupus models, a new study reveals.
Jun 20, 2024
0
83
A study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential novel approach for treating autoimmune diseases like rheumatoid arthritis—preventing antibodies and immune cells from leaving ...
Jun 17, 2024
0
50
A joint team effort led by Dr. Haruhisa Inoue (Professor, Department of Cell Growth and Differentiation, CiRA) has established iPS cells from two patients with EYS-associated retinal dystrophies (EYS-RD) and converted them ...
May 17, 2024
0
0
New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children. The work has been published in JCI Insight.
May 8, 2024
0
1
Researchers from the University of Michigan Health Rogel Cancer Center have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. The test could potentially facilitate early detection ...
Apr 16, 2024
0
37
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood. Recently, researchers at the GOFARR Laboratory for Organ Regenerative ...
Apr 8, 2024
0
0
Scientists have taken a major step towards developing a blood test that could identify millions of people who unknowingly spread tuberculosis.
Mar 22, 2024
0
72
Pancreatic cancer carries the highest mortality rate of all major cancers and is projected to become the second-leading cause of cancer-related deaths in the United States by 2030. It is especially difficult to treat because ...
Mar 6, 2024
0
1
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have made progress in exploring potential treatments for skin tumors associated with neurofibromatosis type 1. Their findings in cell models have been published ...
Feb 13, 2024
0
2
Inflammation in the gut can trigger a doom loop of sorts. The condition messes with the sensitive relationships between food, digestive acids, microbes and the immune system in ways that can promote further inflammation and, ...
Jan 24, 2024
0
77
